Last reviewed · How we verify

NCT03391180

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances: A Randomized Controlled Trial

Status unknown NA Last updated 4 January 2018
What this trial tests

NA trial testing ICON Remineralization in White Spot Lesion in 120 participants. Status unknown.

Timeline
1 February 2018
Primary endpoint
1 April 2018
1 July 2018

Quick facts

Lead sponsorRiyadh Colleges of Dentistry and Pharmacy
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment120
Start date1 February 2018
Primary completion1 April 2018
Estimated completion1 July 2018
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Riyadh Colleges of Dentistry and Pharmacy

Who can join

12 and older, any sex, with White Spot Lesion. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for White Spot Lesion

Currently open trials in the same condition.

Other Riyadh Colleges of Dentistry and Pharmacy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03391180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing